The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schneider, H.
Right arrow Articles by Rudd, C. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schneider, H.
Right arrow Articles by Rudd, C. E.
The Journal of Immunology, 2002, 169: 3475-3479.
Copyright © 2002 by The American Association of Immunologists


Cutting Edge

Cutting Edge: CTLA-4 (CD152) Differentially Regulates Mitogen-Activated Protein Kinases (Extracellular Signal-Regulated Kinase and c-Jun N-Terminal Kinase) in CD4+ T Cells from Receptor/Ligand-Deficient Mice1

Helga Schneider*,{dagger}, Didier A. Mandelbrot§, Rebecca J. Greenwald§, Fai Ng||, Robert Lechler||, Arlene H. Sharpe{ddagger},§ and Christopher E. Rudd2,*,{ddagger}

* Department of Cancer Immunology and AIDS, Dana-Farber Cancer Institute, Departments of {dagger} Medicine and {ddagger} Pathology, Harvard Medical School, and § Immunology Research Division, Department of Pathology, Brigham and Women’s Hospital, Boston, MA 02115; and Departments of Hematology and || Immunology, Faculty of Medicine, Imperial College of Science, Technology and Medicine, Hammersmith Hospital, London, United Kingdom

Although CTLA-4 (CD152) has potent inhibitory effects on T cell function, the signaling events affected by this coreceptor remain to be fully defined. Mitogen-activated protein kinases (MAPK) extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) act as crucial regulators of multiple aspects of cell function. Ab ligation studies have reported an inhibitory effect of CTLA-4 on TCR-induced ERK and JNK activation. In this study, we have re-examined the specificity of CTLA-4 inhibition of MAPKs by using natural ligand with ex vivo-purified CD4+ T cells deficient in CD80 and CD86 (double knockout), or CTLA-4, CD80, and CD86 (triple knockout). Under these conditions, CTLA-4 ligation was found to up-regulate and sustain JNK activation, while inhibiting ERK activity. At the same time, JNK activation could not account for CTLA-4 induction of TGF-{beta} production. Our findings demonstrate that CTLA-4 cosignaling is more complex than previously appreciated, with an ability to differentially regulate members of the MAPK family in T cells.




This article has been cited by other articles:


Home page
BloodHome page
J. Kurtz, F. Raval, C. Vallot, J. Der, and M. Sykes
CTLA-4 on alloreactive CD4 T cells interacts with recipient CD80/86 to promote tolerance
Blood, April 9, 2009; 113(15): 3475 - 3484.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
F. S. Hodi
Cytotoxic T-Lymphocyte Associated Antigen-4
Clin. Cancer Res., September 15, 2007; 13(18): 5238 - 5242.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
V. A. Love, N. Grabie, P. Duramad, G. Stavrakis, A. Sharpe, and A. Lichtman
CTLA-4 Ablation and Interleukin-12 Driven Differentiation Synergistically Augment Cardiac Pathogenicity of Cytotoxic T Lymphocytes
Circ. Res., August 3, 2007; 101(3): 248 - 257.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
B. Wei, S. da Rocha Dias, H. Wang, and C. E. Rudd
CTL-Associated Antigen-4 Ligation Induces Rapid T Cell Polarization That Depends on Phosphatidylinositol 3-Kinase, Vav-1, Cdc42, and Myosin Light Chain Kinase
J. Immunol., July 1, 2007; 179(1): 400 - 408.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
J. Bodor, Z. Fehervari, B. Diamond, and S. Sakaguchi
Regulatory T cell-mediated suppression: potential role of ICER
J. Leukoc. Biol., January 1, 2007; 81(1): 161 - 167.
[Abstract] [Full Text] [PDF]


Home page
ScienceHome page
H. Schneider, J. Downey, A. Smith, B. H. Zinselmeyer, C. Rush, J. M. Brewer, B. Wei, N. Hogg, P. Garside, and C. E. Rudd
Reversal of the TCR Stop Signal by CTLA-4
Science, September 29, 2006; 313(5795): 1972 - 1975.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
P. J. S. Stork and T. J. Dillon
Multiple roles of Rap1 in hematopoietic cells: complementary versus antagonistic functions
Blood, November 1, 2005; 106(9): 2952 - 2961.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Schneider, E. Valk, S. da Rocha Dias, B. Wei, and C. E. Rudd
CTLA-4 up-regulation of lymphocyte function-associated antigen 1 adhesion and clustering as an alternate basis for coreceptor function
PNAS, September 6, 2005; 102(36): 12861 - 12866.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
T. J. Dillon, K. D. Carey, S. A. Wetzel, D. C. Parker, and P. J. S. Stork
Regulation of the Small GTPase Rap1 and Extracellular Signal-Regulated Kinases by the Costimulatory Molecule CTLA-4
Mol. Cell. Biol., May 15, 2005; 25(10): 4117 - 4128.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
H. Ben-David, M. Sela, and E. Mozes
Down-regulation of myasthenogenic T cell responses by a dual altered peptide ligand via CD4+CD25+-regulated events leading to apoptosis
PNAS, February 8, 2005; 102(6): 2028 - 2033.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. M. Wahl, J. Swisher, N. McCartney-Francis, and W. Chen
TGF-{beta}: the perpetrator of immune suppression by regulatory T cells and suicidal T cells
J. Leukoc. Biol., July 1, 2004; 76(1): 15 - 24.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2002 by The American Association of Immunologists, Inc. All rights reserved.